Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/92113
Title: Tumor cell intrinsic Toll-like receptor 4 signaling promotes melanoma progression and metastatic dissemination
Author(s): Rogava, MeriLook up in the Integrated Authority File of the German National Library
Braun, AndreasLook up in the Integrated Authority File of the German National Library
Sluis, Tetje Cornelia
Shridhar, NaveenLook up in the Integrated Authority File of the German National Library
Tüting, Thomas
Gaffal, EvelynLook up in the Integrated Authority File of the German National Library
Issue Date: 2022
Type: Article
Language: English
URN: urn:nbn:de:gbv:ma9:1-1981185920-940657
Subjects: Dedifferentiation
Melanoma
Metastasis
Migration
TLR4
Abstract: Most melanoma-associated deaths result from the early development of metastasis. Toll-like receptor 4 (TLR4) expression on nontumor cells is well known to contribute to tumor development and metastatic progression. The role of TLR4 expression on tumor cells however is less well understood. Here we describe TLR4 as a driver of tumor progression and metastatic spread of melanoma cells by employing a transplantable mouse melanoma model. HCmel12 melanoma cells lacking functional TLR4 showed increased sensitivity to tumor necrosis factor α induced cell killing in vitro compared to cells with intact TLR4. Interestingly, TLR4 knockout melanoma cells also showed impaired migratory capacity in vitro and a significantly reduced ability to metastasize to the lungs after subcutaneous transplantation in vivo. Finally, we demonstrate that activation of TLR4 also promotes migration in a subset of human melanoma cell lines. Our work describes TLR4 as an important mediator of melanoma migration and metastasis and provides a rationale for therapeutic inhibition of TLR4 in melanoma.
URI: https://opendata.uni-halle.de//handle/1981185920/94065
http://dx.doi.org/10.25673/92113
Open Access: Open access publication
License: (CC BY-NC-ND 4.0) Creative Commons Attribution NonCommercial NoDerivatives 4.0(CC BY-NC-ND 4.0) Creative Commons Attribution NonCommercial NoDerivatives 4.0
Sponsor/Funder: Projekt DEAL 2021
Journal Title: International journal of cancer
Publisher: Wiley-Liss
Publisher Place: Bognor Regis
Volume: 150
Issue: 1
Original Publication: 10.1002/ijc.33804
Page Start: 142
Page End: 151
Appears in Collections:Medizinische Fakultät (OA)

Files in This Item:
File Description SizeFormat 
Rogava et al._Tumor cell intrinsic_2022.pdfZweitveröffentlichung14.43 MBAdobe PDFThumbnail
View/Open